Paper41249564
Predicting distant metastasis in early-onset kidney cancer using machine learning: a SEER database study with external validation.
Yuan SP and 2 others. Clin Exp Med, 2025. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Predicting distant metastasis in early-onset kidney cancer using machine learning: a SEER database study with external validation. Papers, record 41249564. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41249564
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Predicting distant metastasis in early-onset kidney cancer using machine learning: a SEER database study with external validation.
- PubMed
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Kidney Neoplasms | Major topic |
| Machine Learning | Major topic |
| Neoplasm Metastasis | Major topic |
| Humans | |
| Male | |
| Female | |
| SEER Program | |
| Middle Aged | |
| Prognosis | |
| Aged | |
| Adult | |
| Support Vector Machine | |
| Logistic Models | |
| ROC Curve |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 2023J011724 | Fujian Provincial Natural Science Foundation of China | PubMed |
Source PubMed
References38
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 33247630 | Patterns of distant metastases in patients with clear cell renal cell carcinoma--A population-based analysis. | Cancer Med | 2021 | https://conductscience.org/library/papers/33247630 | PubMed |
| 2 | 32846785 | An immune scores-based nomogram for predicting overall survival in patients with clear cell renal cell carcinoma. | Medicine (Baltimore) | 2020 | https://conductscience.org/library/papers/32846785 | PubMed |
| 3 | 38837585 | Deciphering lung adenocarcinoma evolution: Integrative single-cell genomics identifies the prognostic lung progression associated signature. | J Cell Mol Med | 2024 | https://conductscience.org/library/papers/38837585 | PubMed |
| 4 | 36100483 | Epidemiology of Renal Cell Carcinoma: 2022 Update. | Eur Urol | 2022 | https://conductscience.org/library/papers/36100483 | PubMed |
| 5 | 39985094 | Age-specific familial risks in cancer as clues to germline genetic and environmental causes: focus on colorectal, endometrial, prostate, kidney, breast and lung cancers. | Hered Cancer Clin Pract | 2025 | https://conductscience.org/library/papers/39985094 | PubMed |
| 6 | 35351362 | Bladder Urothelial Carcinoma: Machine Learning-based Computed Tomography Radiomics for Prediction of Histological Variant. | Acad Radiol | 2022 | https://conductscience.org/library/papers/35351362 | PubMed |
| 7 | 36114898 | Radiomics-based machine-learning method to diagnose prostate cancer using mp-MRI: a comparison between conventional and fused models. | MAGMA | 2023 | https://conductscience.org/library/papers/36114898 | PubMed |
| 8 | 32982441 | Prognostic Role of Prothrombin Time Activity, Prothrombin Time, Albumin/Globulin Ratio, Platelets, Sex, and Fibrinogen in Predicting Recurrence-Free Survival Time of Renal Cancer. | Cancer Manag Res | 2020 | https://conductscience.org/library/papers/32982441 | PubMed |
| 9 | 33791209 | Subgroup-Independent Mapping of Renal Cell Carcinoma-Machine Learning Reveals Prognostic Mitochondrial Gene Signature Beyond Histopathologic Boundaries. | Front Oncol | 2021 | https://conductscience.org/library/papers/33791209 | PubMed |
| 10 | 33931925 | Clinical use of machine learning-based pathomics signature for diagnosis and survival prediction of bladder cancer. | Cancer Sci | 2021 | https://conductscience.org/library/papers/33931925 | PubMed |
| 11 | 36011051 | Epidemiology and Prevention of Renal Cell Carcinoma. | Cancers (Basel) | 2022 | https://conductscience.org/library/papers/36011051 | PubMed |
| 12 | 31767543 | Development of a Deep Learning Algorithm for the Histopathologic Diagnosis and Gleason Grading of Prostate Cancer Biopsies: A Pilot Study. | Eur Urol Focus | 2021 | https://conductscience.org/library/papers/31767543 | PubMed |
| 13 | 34824449 | Machine learning-based pathomics signature could act as a novel prognostic marker for patients with clear cell renal cell carcinoma. | Br J Cancer | 2022 | https://conductscience.org/library/papers/34824449 | PubMed |
| 14 | 32895914 | Clinical use of a machine learning histopathological image signature in diagnosis and survival prediction of clear cell renal cell carcinoma. | Int J Cancer | 2021 | https://conductscience.org/library/papers/32895914 | PubMed |
| 15 | 33646127 | Machine Learning Approach to Predict the Probability of Recurrence of Renal Cell Carcinoma After Surgery: Prediction Model Development Study. | JMIR Med Inform | 2021 | https://conductscience.org/library/papers/33646127 | PubMed |
| 16 | 33929915 | Prognostic Value of Site-Specific Metastases and Therapeutic Roles of Surgery and Chemotherapy for Patients With Metastatic Renal Pelvis Cancer: A SEER Based Study. | Technol Cancer Res Treat | 2021 | https://conductscience.org/library/papers/33929915 | PubMed |
| 17 | 33739235 | Potential value and impact of data mining and machine learning in clinical diagnostics. | Crit Rev Clin Lab Sci | 2021 | https://conductscience.org/library/papers/33739235 | PubMed |
| 18 | 34497343 | The prognosis and clinicopathological features of different distant metastases patterns in renal cell carcinoma: analysis based on the SEER database. | Sci Rep | 2021 | https://conductscience.org/library/papers/34497343 | PubMed |
| 19 | 36068272 | Is early-onset cancer an emerging global epidemic? Current evidence and future implications. | Nat Rev Clin Oncol | 2022 | https://conductscience.org/library/papers/36068272 | PubMed |
| 20 | 32869954 | Pediatric and young adult renal cell carcinoma. | Pediatr Blood Cancer | 2020 | https://conductscience.org/library/papers/32869954 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41249564
GET https://conductscience.org/api/papers/v1/41249564/references?page=2